BDX

What is BDX?

Founded in 1897 by Maxwell Becton and Fairleigh Dickinson, BD started with a simple mission to improve medical outcomes. Over its long history, it has transformed from a small syringe manufacturer into a massive global leader in medtech. Headquartered in New Jersey, the company has hit major milestones, like creating the first American-made glass syringe and completing the massive 2017 acquisition of C.R. Bard, which really boosted their specialized medical tool portfolio.

The business model is all about being indispensable. They operate through three segments: BD Medical, BD Life Sciences, and BD Interventional. Their product list is huge, ranging from basic needles and catheters to advanced flow cytometry systems used in cancer research and those Pyxis automated cabinets you see in hospitals. Basically, if a patient is in a hospital, they are likely using a BD product. This creates a very stable revenue stream because most of these are disposable items that hospitals have to keep reordering.

Financially, BD is a favorite for dividend-focused investors. They are a Dividend Aristocrat, meaning they have raised their payout for over 50 years straight. While they took on significant debt for past acquisitions, they have been working hard to pay it down and lean out the business. They even spun off their diabetes care unit, Embecta, in 2022 to focus on higher-tech, higher-margin sectors like interventional surgery and molecular diagnostics.

Looking toward 2026, the strategy is built on their BD 2025 plan. They are going all-in on digital health, automation, and AI-integrated diagnostics. By 2026, they want to be the go-to for smart pharmacy tech and home-based care solutions. The goal is to hit steady mid-single-digit revenue growth while boosting profits through better supply chain efficiency and a focus on high-growth areas like immunology. They are shifting away from simple commodities and moving toward complex, data-driven clinical solutions.

What is the XTRM Indicator?

The XTRM (Extreme) Indicator is a proprietary momentum indicator that measures cumulative time spent in extreme territory. Unlike traditional oscillators like RSI that measure a snapshot in time, XTRM accumulates how long an asset remains in oversold or overbought conditions, providing a deeper understanding of momentum exhaustion.

For BDX, monitoring the XTRM indicator provides valuable insights into prolonged extreme conditions. When the XTRM drops significantly below zero (especially below -125), Becton, Dickinson and Co. has been in oversold territory for an extended period, suggesting potential for a reversal. Conversely, high positive XTRM values indicate extended overbought conditions.

Understanding BDX XTRM Signals

• Deep Oversold (XTRM below -125): When BDX XTRM falls below -125, it indicates prolonged time in extreme oversold conditions. This cumulative measure often provides stronger reversal signals than single-day oversold readings.
• Neutral Zone (XTRM near 0): When XTRM hovers around zero, BDX is in a balanced state without extended extreme conditions. This can indicate consolidation or indecision in the market.
• Overbought (XTRM above +10): An XTRM above +10 indicates BDX has been in overbought territory for an extended period, potentially signaling an overextended rally and increased risk of pullback.

Daily vs Weekly XTRM for BDX

This page displays both daily and weekly XTRM for BDX. The daily XTRM tracks short-term cumulative extremes, useful for identifying swing trading opportunities. The weekly XTRM provides a longer-term perspective on momentum exhaustion, helping investors spot major turning points.

By analyzing both timeframes together, you can identify when Becton, Dickinson and Co. is experiencing extreme conditions at multiple time scales, which often leads to the strongest reversal setups.

Historical XTRM Extreme Analysis

Above, we track historical instances when BDX XTRM dropped below -125 (extreme oversold territory). These periods represent times when Becton, Dickinson and Co. spent extended periods in oversold conditions, which historically have presented some of the best buying opportunities. Analyzing how BDX behaved after reaching these extreme XTRM levels can help inform future trading decisions.